Early Skin Toxicity as a Predictive Factor for Tumor Control in Hepatocellular Carcinoma Patients Treated with Sorafenib

INTRODUCTION. Sorafenib is an oral multikinase inhibitor that targets Raf kinase and receptor tyrosine kinases and has led to a longer median overall survival (OS) time and time to progression (TTP) in patients with advanced hepatocellular carcinoma (HCC). This study was conducted to assess the link...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Vincenzi, Bruno, Santini, Daniele, Russo, Antonio, Addeo, Raffaele, Giuliani, Francesco, Montella, Liliana, Rizzo, Sergio, Venditti, Olga, Frezza, Anna Maria, Caraglia, Michele, Colucci, Giuseppe, Del Prete, Salvatore, Tonini, Giuseppe
Formato: Artigo
Idioma:Inglês
Publicado em: AlphaMed Press 2010
Assuntos:
Hepatobiliary
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3227883/
https://ncbi.nlm.nih.gov/pubmed/20051477
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2009-0143
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados